Should you cycle TRT? What the evidence actually says

What did @therestoreclinic actually say?

The creator's answer is simple and unambiguous: TRT is not meant to be cycled. Their reasoning is that testosterone replacement exists to replace hormone production that has already declined, and that decline "is not going to magically start coming back." The conclusion: if you start TRT, expect to stay on it long-term.

This is a direct response to a viewer question, and the creator frames it confidently, without caveats. There is also a transcript error worth noting, where they appear to say "daughter's production" when they clearly meant "testosterone production." That is a transcription artifact, not a clinical error.

Does the science back this up?

Mostly, yes. For men with true primary or secondary hypogonadism, the evidence supports long-term, continuous testosterone replacement rather than cycling. The Endocrine Society's 2018 clinical practice guideline (Bhasin et al., Journal of Clinical Endocrinology and Metabolism) recommends ongoing therapy for men with confirmed hypogonadism, with no language supporting periodic cycling off treatment.

The logic holds biologically. Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal (HPG) axis through negative feedback, reducing or stopping endogenous production. For men whose axis is already compromised, this suppression is not the catastrophic problem it is for healthy men using testosterone for performance enhancement. Their endogenous production was the problem to begin with.

A 2020 review by Rastrelli, Corona, and Maggi in the journal Minerva Endocrinologica confirmed that testosterone therapy in truly hypogonadal men does not meaningfully suppress what little natural production remains and that discontinuation rarely restores function in men with primary testicular failure.

What did they get wrong (or right)?

They got the core claim right. Cycling is a concept borrowed from anabolic steroid use in bodybuilding, where healthy men take supraphysiologic doses and then stop to allow natural production to recover. That logic does not translate cleanly to medically supervised TRT in a hypogonadal patient.

What they glossed over is that the picture is more complicated depending on why someone is on TRT. There is a real and documented population of younger men placed on TRT for secondary hypogonadism, where the testes are functional but the signaling from the brain is the problem. For those patients, alternatives like clomiphene citrate or human chorionic gonadotropin (hCG) can sometimes restore natural production, and some clinicians do use these as either first-line options or as a structured off-ramp from TRT. A 2019 study by Krzastek et al. in Urology found that clomiphene effectively raised testosterone in secondary hypogonadal men while preserving fertility.

The video makes no distinction between primary and secondary hypogonadism. That is a meaningful omission, not a fatal error, but it matters if a younger patient is watching and assuming their situation is identical to someone with primary testicular failure.

What should you actually know?

Whether or not you should consider TRT, and whether cycling has any role, depends heavily on a proper diagnosis. The starting point is always blood work: total testosterone, free testosterone, LH, FSH, and SHBG at minimum. The cause of low testosterone determines the treatment path.

For men with primary hypogonadism, the creator is essentially correct. Testosterone is not coming back without help, and long-term replacement is the clinical standard. For men with secondary hypogonadism, there may be options that preserve or restore natural production before committing to lifetime exogenous testosterone.

It is also worth knowing that stopping TRT abruptly after prolonged use does not mean testosterone levels simply snap back. Post-TRT recovery can take months and is not guaranteed, particularly after years of use. A 2015 paper by Rao et al. in the Journal of Sexual Medicine documented that some men experience prolonged hypogonadism after TRT discontinuation, sometimes requiring additional support like hCG or selective estrogen receptor modulators.

The creator's bottom line, that TRT is a long-term commitment, is sound advice and something anyone starting therapy should understand before the first injection or application.